[cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells]

B Hirsch1, F K Braun, N Al-Yacoub

  • 1Institut für Pathologie, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin. burkhard.hirsch@charite.de

Der Pathologe
|September 3, 2010
PubMed

Insights

CD30 receptor stimulation upregulates cFLIP, enhancing resistance to CD95-mediated apoptosis in cALCL cells. Inhibiting cFLIP restores apoptosis sensitivity, suggesting caution with CD30 antibody therapies for ALCL.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor necrosis factor (TNF) receptors CD30 and CD95 have opposing effects.
  • The crosstalk between CD30 and CD95 signaling is not well understood.
  • Understanding this interaction is crucial for ALCL (anaplastic large cell lymphoma) pathogenesis and therapy.

Purpose of the Study:

  • To investigate the regulatory mechanisms of CD30-induced effects on CD95 signaling in cALCL cell lines.
  • To elucidate the crosstalk between CD30 and CD95 signaling pathways.
  • To determine the role of cFLIP in CD30/CD95 crosstalk and apoptosis resistance.

Main Methods:

  • Flow cytometry was used to assess receptor expression and apoptosis induction.
  • RT-RQ-PCR and immunoblotting analyzed mRNA and protein expression of key signaling molecules (cFLIP, TRAF1, IκBα, caspases).
  • Lentiviral shRNA mediated knockdown of cFLIP to assess its functional role.

Main Results:

  • CD30 ligation induced NFκB-mediated upregulation of cFLIP in cALCL cells.
  • Upregulated cFLIP conferred resistance to CD95-mediated apoptosis.
  • Knockdown of cFLIP restored sensitivity to CD95-induced apoptosis, confirming cFLIP's critical role.

Conclusions:

  • CD30 signaling promotes apoptosis resistance in cALCL cells via cFLIP upregulation.
  • The anti-apoptotic function of CD30 antibodies warrants consideration in therapeutic strategies for ALCL.
  • Targeting cFLIP may represent a therapeutic avenue for overcoming resistance in ALCL.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.